{
    "medicine_id": "e215056d4d31ca8382fda93f882b685cb49ad422",
    "platform_id": "DB00766",
    "metadata": {
        "name": "Amoxi clav 500 mg Tablet coated",
        "composition": "500 mg Clavulanic acid",
        "clinical_particulars": {
            "therapeutic_indications": "Clavulanic acid combined with other antibiotics is indicated to prevent the development of drug resistant strains of bacteria and promotes their therapeutic antibacterial effects L7880 L7904 The following conditions when they produced beta lactamases have been treated with a combination of amoxicillin and clavulanic acid or ticarcillin and clavulanic acid L7880 L7904 Acute otitis media caused by H influenzae and M catarrhalis Sinusitis due to H influenzae and M catarrhalis Lower respiratory tract infections due to Haemophilus influenzae S aureus Klebsiella species and Moraxella catarrhalis Skin and skin structure infections caused by Staphylococcus aureus Escherichia coli and Klebsiella species Urinary Tract Infections due to E coli Klebsiella species of bacteria and Enterobacter species of bacteria S marcescens or S aureus Gynecologic infections due to a variety of bacteria including P melaninogenicus Enterobacter species E Coli species Klebsiella species S aureus S epidermidis Septicemia due to a variety of bacteria including Klebsiella species E Coli species S aureus or Pseudomonas species Bone and joint infections due to S aureus Intraabdominal infections due to E Coli K pnemoniae or B fragilis group A note on susceptibility It should be noted that it is only to be administered in infections that are confirmed or highly likely to be caused by susceptible bacteria Culture and susceptibility tests should be performed if possible and used in selecting whether this antibiotic is prescribed When beta lactamase enzyme production is not detected during microbiological testing clavulanic acid should not be used When these tests are not available patterns of local infection and susceptibility may be used to determine the appropriateness of using clavulanic acid L7880 Ticarcillin with clavulanate has shown particular efficacy in mixed infections in addition to empiric therapy before determining the susceptibility of causative organisms The ticarcillin clavulanic acid combination may prove to be an effective single agent antibiotic therapy to treat infections where a regimen of several drugs may normally be used L7904",
            "contraindications": {
                "disease": "LD50 information Clavulanic acid has demonstrated low oral acute toxicity in adult rodents having an LD50 of more than 2000 mg kg The toxicity of clavulanic acid on pre weaning rats was also studied Gastrointestinal disturbance and mortality occurred even at lower clavulanic acid doses of 125 mg kg L7898 Overdose information Overdose information has been obtained for the combination of amoxicillin and clavulanic acid as these drugs are frequently administered together in a single product L7880 L7886 Changes in fluid and electrolyte balances and gastrointestinal symptoms may occur in the case of an overdose Offer symptomatic treatment or gastrointestinal disturbances while considering the importance of fluid and electrolyte balance This drug may be removed by a session of hemodialysis When coadministered with amoxicillin crystalluria causing renal failure has been observed L7886 Seizures may also occur in a case of overdose or in a patient with renal failure L7904",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Clavulanic acid inactivates some beta lactamase enzymes that are produced by bacteria therefore preventing enzymatic destruction of amoxicillin This helps to treat a variety of bacterial infections which would otherwise be resistant to antibiotics without the addition of clavulanic acid L7880 L7886 L7904",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Clavulanic acid"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Clavulanic acid"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Clavulanic acid"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Clavulanic acid is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may increase the hepatotoxic activities of Clavulanic acid"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Clavulanic acid"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Clavulanic acid"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}